Cargando…
Modification of a Constitutive to Glucose-Responsive Liver-Specific Promoter Resulted in Increased Efficacy of Adeno-Associated Virus Serotype 8-Insulin Gene Therapy of Diabetic Mice
We have previously used a hepatotropic adeno-associated viral (AAV) vector with a modified human insulin gene to treat diabetic mice. The HLP (hybrid liver-specific promoter) used was constitutively active and non-responsive to glucose. In this study, we examined the effects of addition of glucose r...
Autores principales: | Sia, Kian Chuan, Fu, Zhen Ying, Calne, Roy Y., Nathwani, Amit C., Lee, Kok Onn, Gan, Shu Uin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7696068/ https://www.ncbi.nlm.nih.gov/pubmed/33202992 http://dx.doi.org/10.3390/cells9112474 |
Ejemplares similares
-
Development of a liver‐specific Tet‐off AAV8 vector for improved safety of insulin gene therapy for diabetes
por: Gan, Shu Uin, et al.
Publicado: (2019) -
Immunosuppression overcomes insulin- and vector-specific immune responses that limit efficacy of AAV2/8-mediated insulin gene therapy in NOD mice
por: Recino, Asha, et al.
Publicado: (2018) -
First use of gene therapy to treat growth hormone resistant dwarfism in a mouse model
por: Sia, Kian Chuan, et al.
Publicado: (2022) -
Infectivity of adeno-associated virus serotypes in mouse testis
por: Rajasekaran, Santhanasabapathy, et al.
Publicado: (2018) -
Post‐translational modifications in capsid proteins of recombinant adeno‐associated virus (AAV) 1‐rh10 serotypes
por: Mary, Bertin, et al.
Publicado: (2019)